Wendy Erler

With a true passion for patients, and dedication to connecting people in need to resources, services and people, Wendy has built her patient advocacy career in many rare disease communities and oncology. Wendy Erler is the Vice President of Patient Experience, STAR and Advocacy at Alexion Pharmaceuticals where she is responsible for leading the enterprise patient centered innovation model to gather and incorporate patient insights throughout the drug development and commercialization processes. She leads the Global Patient Advocacy function and has responsibility the advocacy team. Previously, Ms. Erler was on the executive leadership team at Wave Life Sciences where she led Patient Advocacy and Commercial. During her tenure, she built both functions and developed the commercialization strategy as the organization initiated its rare disease clinical trials in Duchenne muscular dystrophy and Huntington’s disease. Prior to Wave, Wendy held roles of increasing responsibility at Biogen, starting in field sales and advancing through the commercial organization before serving as the patient advocacy lead for several rare disease programs including ALS, SMA, IPF, and Hemophilia. In these roles she gained experience in Newborn Screening, public policy, HTA’s, and bringing the patient voice into all aspects of drug development.

Wendy serves on the Life Science Cares Board of Advisors, the Huntington Disease Society of America Board and the Board of the Jett Foundation.

Wendy graduated from Miami University and earned her MBA from St. Joseph’s University.